BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 4, 2009
View Archived Issues
GSK-2126458 shows potent preclinical antitumor activity; phase I trial under way
Read More
New camptothecin conjugate evaluated in phase I trial in advanced solid tumors
Read More
FIELD trial data support beneficial effects of fenofibrate in type 2 diabetes patients
Read More
Prasugrel more effective than clopidogrel in CAD patients with type 2 diabetes
Read More
Small-molecule compound BRA-101 reduces DSS-induced murine colitis
Read More
Novel AR antagonist ZR-291 exhibits potent preclinical activity in prostate cancer
Read More
Novartis' Onbrez Breezhaler approved in E.U. for patients with COPD
Read More
Daiichi Sankyo reports results from Q2 of 2009, ended September 30
Read More
Vertex reports results from third quarter of 2009
Read More
MicroDose Therapeutx acquires EPX-16006 from Epix
Read More
Johnson & Johnson submits NDA to FDA for tapentadol ER tablets for chronic pain
Read More
New recombinant Xyntha now available in Canada
Read More
Stryker agrees to acquire Ascent Healthcare Solutions
Read More
DiaMedica expands into neurological disorders through acquisition of Sanomune
Read More
Pacira reports results of phase III Exparel trial in postoperative pain
Read More
Roche reports encouraging results from phase III trials of taspoglutide in diabetes
Read More
Javelin submits NDA to FDA for Dyloject for acute moderate to severe pain in adults
Read More
Watson Pharmaceuticals acquires Arrow Group
Read More
Bayer Schering Pharma claims novel series of adenosine A1 agonists
Read More
Novel antibacterial agents disclosed by AstraZeneca
Read More
Merck & Co. describes beta3-adrenoceptor agonists for urinary incontinence
Read More
Agreement reached on U.S. approval pathway for Pompe disease treatment
Read More
Endo provides regulatory update on Aveed for men with low testosterone
Read More
FDA approves AstraZeneca's Seroquel for pediatric schizophrenia and bipolar mania
Read More
ExonHit Therapeutics launches AclarusDx Alzheimer's test
Read More
Epigallocatechin gallate possibly beneficial in open-angle glaucoma patients
Read More